Lesaka Technologies, Inc. (LSAK) Misses Q2 EPS by 1c

Lesaka Technologies, Inc. (NASDAQ: LSAK) reported Q2 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $143.9 million versus the consensus estimate of $144.45 million.

For earnings history and earnings-related data on Lesaka Technologies, Inc. (LSAK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c